Trials / Completed
CompletedNCT02667652
The Curative Effect of the Length of the Jejunum Exclusion in Grstric Bypass Surgery for Type 2 Diabetes
The Curative Effect of the Length of the Jejunum Exclusion in Grstric Bypass Surgery for Type 2 Diabetes:a Randomized Controlled Trials
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Weidong Tong · Academic / Other
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the curative effect of the length of the jejunum exclusion in gastric surgry for T2DM and metabolic syndrome,and to draft Scientific and reasonable operation parameters.
Detailed description
Currently, there is a growing evidence supports the efficacy of Roux-en-Y gastric bypass for the treatment of Type 2 diabetes mellitus. However,there still have a great controversy about the operation parameters. With randomized controlled trial, Patients of BMI\>21kg/m2 with type 2 diabetes were randomly divided into two groups: short biliarypancreatic limb:50cm;long biliarypancreatic limb :100cm. The investigators followed-up 3,6,12,24 months of the change of BMI,FBG,HbA1c,Blood pressure,Blood fat after surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | short biliarypancreatic limb | biliarypancreatic limb:50cm;roux limb:150cm. |
| PROCEDURE | long biliarypancreatic limb | biliarypancreatic limb:100cm;roux limb:100cm. |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2019-09-01
- Completion
- 2020-08-01
- First posted
- 2016-01-29
- Last updated
- 2022-05-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02667652. Inclusion in this directory is not an endorsement.